HeartSciences reported cash from operations of -$1.68M and free cash flow of -$1.68M for the quarter ended Apr 2026, down 3.5% year over year. This cash flow statement covers 19 quarters of results from Jul 2021 through Apr 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jul2021 | Oct2021 | Jan2022 | Apr2022 | Jul2022 | Oct2022 | Jan2023 | Apr2023 | Jul2023 | Oct2023 | Jan2024 | Apr2024 | Jul2024 | Oct2024 | Jan2025 | Apr2025 | Jul2025 | Oct2025 | Apr2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||
| Net Income | -0.75M | -1.03M | -1.24M | -2.05M | -1.57M | -1.81M | -1.34M | -1.63M | -1.37M | -1.75M | -1.64M | -1.90M | -2.10M | -2.10M | -2.55M | -2.10M | -2.06M | -2.35M | -2.76M |
| Share-based CompensationStock Comp. | 0.00M | 808.00 | 0.12M | -0.05M | 1.50M | 1.70M | 1.70M | 1.07M | 1.60M | 1.60M | 0.07M | 0.05M | 1.50M | 1.50M | 0.10M | 0.78M | 1.50M | 0.32M | |
| Cash from OperationsCash from Ops. | -0.72M | -0.77M | -0.97M | -1.19M | -1.81M | -1.08M | -1.02M | -1.86M | -1.40M | -0.99M | -2.10M | -1.58M | -2.02M | -2.18M | -1.62M | -1.59M | -1.95M | -2.33M | -1.68M |
| Depreciation, Depletion & Amortization | |||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.02M | 0.01M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.03M | 0.03M | ||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | 0.12M | 0.06M | 0.02M | 0.11M | 0.11M | 0.11M | 0.26M | 0.10M | |||||||||||
| Change in Working Capital | |||||||||||||||||||
| Change in ReceivablesChange Receivables | -0.00M | 0.01M | 0.00M | -0.00M | |||||||||||||||
| Change in InventoryChange Inventory | -0.03M | -0.02M | -0.02M | 173.00 | 0.00M | -760.00 | -550.00 | -0.00M | -0.04M | 0.01M | 0.01M | -760.00 | -0.00M | -760.00 | 0.01M | -0.00M | |||
| Change in Account PayablesChange Payables | -0.08M | 0.17M | -0.03M | 0.30M | -0.16M | 0.34M | 0.25M | -0.39M | -0.18M | 0.63M | -0.67M | 0.03M | -0.05M | -0.12M | 0.13M | -0.09M | -0.04M | 0.03M | -0.09M |
| Change in Accured ExpensesChange Accured Exp. | 0.05M | 0.14M | 0.30M | 0.37M | -0.48M | 0.25M | -0.04M | -0.04M | 0.03M | -0.07M | -0.10M | 0.08M | -0.04M | -0.22M | 0.02M | 0.26M | 0.17M | -0.33M | 0.22M |
| Investing Activities | |||||||||||||||||||
| Capital ExpendituresCapex | 0.01M | 0.00M | 0.01M | 0.00M | 0.00M | 0.01M | 0.05M | ||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.01M | -0.00M | -0.01M | -0.00M | -0.00M | -0.05M | -0.07M | -833.00 | -0.01M | -0.02M | -0.01M | -814.00 | -0.02M | ||||||
| Financing Activities | |||||||||||||||||||
| Other financing activitiesOther financing | 0.02M | -1.85M | |||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 1.92M | 0.78M | 5.17M | -0.12M | -0.12M | 1.60M | 0.32M | 0.51M | 9.13M | 0.38M | 0.55M | 1.90M | 0.18M | 0.10M | 3.65M | 1.51M | -0.06M | ||
| Change in Capital Stock | |||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 0.16M | 0.01M | 0.11M | 0.15M | 0.01M | 0.00M | 0.15M | 0.60M | 0.60M | ||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 5.19M | 0.80M | 0.63M | 0.37M | 0.17M | ||||||||||||||
| Additional items | |||||||||||||||||||
| Change in Cash | -0.72M | 0.36M | 0.96M | -0.41M | 3.35M | -1.20M | -1.15M | -0.27M | -1.08M | -0.48M | 6.98M | -1.27M | -1.47M | -0.29M | -1.46M | -1.50M | 1.69M | -0.84M | -1.74M |
| Free Cash FlowFCF | -0.72M | -0.77M | -0.97M | -1.19M | -1.82M | -1.08M | -1.02M | -1.87M | -1.41M | -0.99M | -2.11M | -1.63M | -2.02M | -2.18M | -1.62M | -1.59M | -1.95M | -2.33M | -1.68M |
| Net Cash FlowNCF | -0.72M | -0.77M | 0.96M | -0.41M | 3.35M | -1.20M | -1.15M | -0.27M | -1.08M | -0.48M | 6.98M | -1.27M | -1.47M | -0.29M | -1.46M | -1.50M | 1.69M | -0.84M | -1.74M |